Search research articles
Contact Us
Filters
Showing results (351-360 of 517) with videos related to
Page
of 52
Sort By:
British Journal of Pharmacology
|
October 27, 2019
Cu<sup>II</sup> (atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease
Adam Southon, Kathryn Szostak, Karla M Acevedo, et al.
Molecular Psychiatry
|
August 17, 2021
The acute phase protein lactoferrin is a key feature of Alzheimer's disease and predictor of Aβ burden through induction of APP amyloidogenic processing
Andrew Tsatsanis, Andrew N McCorkindale, Bruce X Wong, et al.
ACS Chemical Neuroscience
|
May 30, 2026
Cu(ATSM) Restores Blood-Brain Barrier Abundance of P-Glycoprotein and Improves Cognitive Function in the APP/PS1 Mouse Model of Alzheimer's Disease
Jae Pyun, Asif Noor, Pranav Runwal, et al.
Redox Biology
|
February 24, 2015
Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease
Kiersten L Berggren, Jianfang Chen, Julia Fox, et al.
Redox Biology
|
September 10, 2017
Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis
Shashank Masaldan, Sharnel A S Clatworthy, Cristina Gamell, et al.
ACS Chemical Biology
|
May 10, 2013
Increasing intracellular bioavailable copper selectively targets prostate cancer cells
Michael A Cater, Helen B Pearson, Kamil Wolyniec, et al.
Journal of Structural Biology
|
August 15, 2000
Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease
R A Cherny, K J Barnham, T Lynch, et al.
Metallomics : Integrated Biometal Science
|
December 18, 2013
Altered transition metal homeostasis in Niemann-Pick disease, type C1
Ya Hui Hung, Noel G Faux, David W Killilea, et al.
Diabetes Care
|
May 24, 2014
Response to comment on Moore et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes care 2013;36:2981-2987
Eileen M Moore, Alastair G Mander, David Ames, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 21, 2022
Novel Antidepressant-Like Properties of the Iron Chelator Deferiprone in a Mouse Model of Depression
Volkan Uzungil, Harvey Tran, Connor Aitken, et al.
Page
of 52
Search research articles
Search
Showing results (351-360 of 517) with videos related to
Sort By:
Page
of 52
British Journal of Pharmacology
|
October 27, 2019
Cu<sup>II</sup> (atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease
Adam Southon, Kathryn Szostak, Karla M Acevedo, et al.
Molecular Psychiatry
|
August 17, 2021
The acute phase protein lactoferrin is a key feature of Alzheimer's disease and predictor of Aβ burden through induction of APP amyloidogenic processing
Andrew Tsatsanis, Andrew N McCorkindale, Bruce X Wong, et al.
ACS Chemical Neuroscience
|
May 30, 2026
Cu(ATSM) Restores Blood-Brain Barrier Abundance of P-Glycoprotein and Improves Cognitive Function in the APP/PS1 Mouse Model of Alzheimer's Disease
Jae Pyun, Asif Noor, Pranav Runwal, et al.
Redox Biology
|
February 24, 2015
Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease
Kiersten L Berggren, Jianfang Chen, Julia Fox, et al.
Redox Biology
|
September 10, 2017
Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis
Shashank Masaldan, Sharnel A S Clatworthy, Cristina Gamell, et al.
ACS Chemical Biology
|
May 10, 2013
Increasing intracellular bioavailable copper selectively targets prostate cancer cells
Michael A Cater, Helen B Pearson, Kamil Wolyniec, et al.
Journal of Structural Biology
|
August 15, 2000
Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease
R A Cherny, K J Barnham, T Lynch, et al.
Metallomics : Integrated Biometal Science
|
December 18, 2013
Altered transition metal homeostasis in Niemann-Pick disease, type C1
Ya Hui Hung, Noel G Faux, David W Killilea, et al.
Diabetes Care
|
May 24, 2014
Response to comment on Moore et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes care 2013;36:2981-2987
Eileen M Moore, Alastair G Mander, David Ames, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 21, 2022
Novel Antidepressant-Like Properties of the Iron Chelator Deferiprone in a Mouse Model of Depression
Volkan Uzungil, Harvey Tran, Connor Aitken, et al.
Page
of 52